Growth Hormone Treatment for Idiopathic Short Stature
Authors:
- Leona CuttlerLCLeona Cuttler
- J. B. SilversJSJ. B. Silvers
- 1 February 2004
- journal article
- editorial
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 158 (2) , 108-110
Abstract
The July 2003 approval of biosynthetic growth hormone (GH) by the Food and Drug Administration (FDA) for treating children with idiopathic short stature has raiKeywords
This publication has 6 references indexed in Scilit:
- The psychosocial consequences of short stature: a review of the evidenceBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Growth Hormone Use in Normal, Short Children — A Plea for ReasonNew England Journal of Medicine, 1999
- Psychosocial Outcome of Children Evaluated for Short StatureArchives of Pediatrics & Adolescent Medicine, 1997
- Psychological response to growth hormone treatment in short normal children.Archives of Disease in Childhood, 1996
- Psychosocial growth failure: a positive response to growth hormone and placeboActa Paediatrica, 1992
- Growth Hormone Therapy and the Short End of the StickNew England Journal of Medicine, 1988